Opinion: The Frustrating Process of Manuscript Submission

We suggest a centralized facility for submitting to journals—one that would benefit scientists and not only publishers.

Written byTim Birkhead and Robert Montgomerie
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© BRYAN SATALINOIn October 1676, when Antoni van Leeuwenhoek wanted to tell the world about his discovery of protists and bacteria, he simply sent a letter—in low Dutch—to Henry Oldenburg who was editor of the Philosophical Transactions of the Royal Society of London. Oldenburg translated the letter into English, shortened it somewhat, and published it less than five months later in the March 1677 issue of the journal, thereby founding the field of microbiology (Phil Trans R Soc B, 370:20140344, 2015). In those days, publication of scientific papers (letters) was largely at the whim of the journal editor, and was typically rapid.

For the next three centuries, the process of publishing papers remained remarkably consistent for scientists: write, submit, respond to reviews or try elsewhere (repeat as needed), and develop final copy—then wait weeks, months, or even years to see your work in print. Successively, 20th-century typewriters, then mainframe (and later personal) computers and word processors made writing and revising easier. Email and the Internet would, we hoped, streamline the process of submitting and reviewing manuscripts and reviews, but there is little evidence that these two innovations made it more efficient for authors.

In our experience, it takes no more than 15 minutes to book a flight online, eight minutes to rent a car, and fewer than 30 seconds to buy a book from Amazon. So why ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies